Navigation Links
GPhA Congratulates President-Elect Barack Obama and New Congress and Urges Action on Increasing Access to Generic -- and Biogeneric -- Medicines
Date:11/5/2008

ARLINGTON, Va., Nov. 5 /PRNewswire-USNewswire/ -- The Generic Pharmaceutical Association (GPhA) released the following statement today from GPhA President and CEO Kathleen Jaeger on the 2008 election results:

All across the country yesterday, voters went to the polls with economic issues top of mind. Our new President and new Congress must now tackle the serious challenges facing our economy, including rising health care costs. One way to significantly reduce health care costs is for our elected officials to increase access to affordable generic - and biogeneric - medicines.

The generic industry congratulates President-Elect Barack Obama and the new Congress and looks forward to working with them in addressing critical health care issues. President-elect Obama has stated his commitment to increasing access to generic medicines to help Americans obtain safe and effective medicines at affordable prices. At GPhA's Annual Policy Conference this past September, Senator Obama's health policy advisor said that President-elect Obama supports increased funding to ensure a strong FDA, and would also address important issues including citizen petitions, state carve-outs, Free Trade Agreements (FTAs) and authorized generics as part of his health care agenda.

Moreover, President-Elect Obama has expressed his strong support for bringing lifesaving, affordable biogeneric medicines to patients in need. His campaign stated that, as President, he would support legislation to create a biogenerics approval pathway with as short an exclusivity period as possible to ensure timely consumer access. That's welcome news to the countless Americans who are struggling to afford the extremely high costs of brand biopharmaceutical medicines.

GPhA also stands ready to work with the Obama Administration and Congress to ensure the safety of all medicines. Safety must always be our number one priority.

GPhA also congratulates Senator John McCain for running a strong campaign, we appreciate his past support for increasing access to more affordable generic medicines, and we look forward to his continued leadership on issues related to affordable health care for all Americans.

2009 will be a year of great challenges for the new Administration and new Congress, but it can also be a year of extraordinary opportunities. We look forward to working with President-Elect Obama and all members of Congress. There is no doubt that bringing affordable generic and biogeneric medicines to consumers will help our new President and Congress deal with rising health care costs. Generic - and biogeneric - medicines are truly the right choice for better health.

GPhA represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk active pharmaceutical chemicals, and suppliers of other goods and services to the generic drug industry. Generics represent 65% of the total prescriptions dispensed in the United States, but only 20% of all dollars spent on prescription drugs. For more information about the industry, visit http://www.gphaonline.org.


'/>"/>
SOURCE Generic Pharmaceutical Association (GPhA)
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. WellPoint Congratulates President-Elect Barack Obama
2. Bright Horizons Congratulates 76 Clients Named to Working Mothers 100 Best
3. The Gerontological Society of America congratulates new Hartford Doctoral Fellows
4. aloft(SM) hotels Congratulates Hometown Olympic Swimmer and Gold Medalist Brendan Hansen Friday, September 12, 2008
5. American Lung Association Congratulates the U.S. House of Representatives for Passage of Historic Tobacco Legislation
6. ACP congratulates Congress on veto override of H.R. 6331
7. Eatn Park Restaurants - States Largest Family Dining Chain - Congratulates Pennsylvania House and Senate for Passing Smoking Ban
8. Executive Director of cbm US congratulates UN on Malaria Campaign
9. Coalition for 21st Century Medicine Congratulates U.S. Senate on Passage of Genetic Information Nondiscrimination Act
10. SNM congratulates NOPR and its supporting organizations on successful conclusion of project
11. Internet2 Congratulates FCC Rural Health Care Pilot Program Grant Awardees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... markets and sells medical devices and wearable sleep respiratory ... strategic cooperation agreement with Hongyuan Supply Chain Management Co., ... June 20, 2016, to develop Dehaier,s new Internet medical ... Dehaier will leverage Hongyuan Supply Chain,s sales platform to ...
Breaking Medicine Technology: